Arkolith/Insider Trading/CYTK/Form 4

Callos Andrew

EVP, Chief Commercial OfficerCYTOKINETICS INC (CYTK) · full profile →Form 4 · filed Jun 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)15K$23.26$349K74K
Jun 1, 2026Sell(S)15K$74.08$1.1M59K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)15K—$039K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001061983-26-000065) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML